Zobrazeno 1 - 7 of 7 pro vyhledávání: '"Brnabic Alan JM"'
1
Akademický článek
Treatment and outcomes of an Australian cohort of outpatients with bipolar I or schizoaffective disorder over twenty-four months: implications for clinical practice
Autor: Kulkarni Jayashri, Filia Sacha, Berk Lesley, Filia Kate, Dodd Seetal, de Castella Anthony, Brnabic Alan JM, Lowry Amanda J, Kelin Katarina, Montgomery William, Fitzgerald Paul B, Berk Michael
Publikováno v: BMC Psychiatry, Vol 12, Iss 1, p 228 (2012)
Abstract Background The Bipolar Comprehensive Outcomes Study (BCOS) is a 2-year, prospective, non-interventional, observational study designed to explore the clinical and functional outcomes associated with ‘real-world’ treatment of participants
Externí odkaz: https://doaj.org/article/16fd686686224684a6c567b1f05b4a23
Zobrazit plný text záznamu
4
Akademický článek
The epidemiology and burden of Alzheimer's disease in Taiwan utilizing data from the National Health Insurance Research Database.
Autor: Hung YN; School of Gerontology Health Management and Master Program in Long-Term Care, College of Nursing, Taipei Medical University, Taipei, Taiwan, Republic of China., Kadziola Z; Real World Analytics, Eli Lilly GmbH, Vienna, Austria., Brnabic AJ; Real World Analytics, Eli Lilly Australia Pty Ltd, West Ryde, NSW, Australia., Yeh JF; Department of Medicine, Eli Lilly and Company, Taiwan, Republic of China., Fuh JL; Department of Neurology, Neurological Institute, Taipei Veterans General Hospital; Faculty of Medicine, School of Medicine, National Yang Ming University., Hwang JP; Department of Psychiatry, Taipei Veterans General Hospital; Division of Psychiatry, School of Medicine, National Yang-Ming University, Taipei, Taiwan, Republic of China., Montgomery W; Eli Lilly Australia Pty Ltd, West Ryde, NSW, Australia.
Publikováno v: ClinicoEconomics and outcomes research : CEOR [Clinicoecon Outcomes Res] 2016 Aug 02; Vol. 8, pp. 387-95. Date of Electronic Publication: 2016 Aug 02 (Print Publication: 2016).
Zobrazit plný text záznamu
5
Akademický článek
Comparison of patients undergoing switching versus augmentation of antipsychotic medications during treatment for schizophrenia.
Autor: Ascher-Svanum H; Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Indiana, USA., Brnabic AJ, Lawson AH, Kinon BJ, Stauffer VL, Feldman PD, Kelin K
Publikováno v: Neuropsychiatric disease and treatment [Neuropsychiatr Dis Treat] 2012; Vol. 8, pp. 113-8. Date of Electronic Publication: 2012 Mar 15.
Zobrazit plný text záznamu
6
Akademický článek
Treatment discontinuation and clinical outcomes in the 1-year naturalistic treatment of patients with schizophrenia at risk of treatment nonadherence.
Autor: Kelin K; Eli Lilly Australia Pty Ltd, West Ryde, NSW, Australia;, Lambert T Jr, Brnabic AJ, Newton R, Ye W, Escamilla RI, Chen KP, Don L, Montgomery W, Karagianis J, Ascher-Svanum H
Publikováno v: Patient preference and adherence [Patient Prefer Adherence] 2011; Vol. 5, pp. 213-22. Date of Electronic Publication: 2011 May 09.
Zobrazit plný text záznamu
7
Akademický článek
Baseline characteristics and initial treatment decisions for patients with schizophrenia at risk of treatment nonadherence.
Autor: Kelin K; Eli Lilly Australia Pty Ltd, West Ryde, NSW, Australia;, Brnabic AJ, Newton R, Escamilla RI, Chuo LJ, Simu M, Ye W, Montgomery W, Karagianis J, Ascher-Svanum H
Publikováno v: Patient preference and adherence [Patient Prefer Adherence] 2010 Sep 07; Vol. 4, pp. 301-11. Date of Electronic Publication: 2010 Sep 07.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje